The American company that makes Tylenol says the FDA should not make proposed changes to the product’s safety label to reflect a possible connection to autism.

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

On Saturday, Oct. 25, 2025, from 10 a.m. to 2 p.m., the Lincoln Parish Sheriff’s Office will partner with the Drug Enforcement Administration to host ...

The FDA defied the advice of its own drug safety experts to warn pregnant women about Tylenol for nearly a decade, internal documents reveal.

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

Kenvue, the American company that makes Tylenol, says the FDA should not make proposed changes to the drug's safety label ...

Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to ...

Kenvue, the owners of Tylenol, are pushing back on claims that acetaminophen—the chemical compound in their popular ...

Tylenol's maker is pushing back against proposed safety label changes that would include autism-related pregnancy warnings.